Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4319145)

Published in JMIR Mhealth Uhealth on January 21, 2015

Authors

Trevor van Mierlo1, Rachel Fournier, Richard Fedorak

Author Affiliations

1: Evolution Health Systems Inc., Toronto, ON, Canada. tvanmierlo@evolutionhs.com.

Articles cited by this

Adherence to medication. N Engl J Med (2005) 39.77

The impact of patient-centered care on outcomes. J Fam Pract (2000) 15.07

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78

A systematic review of the associations between dose regimens and medication compliance. Clin Ther (2001) 9.23

Medication compliance and persistence: terminology and definitions. Value Health (2008) 7.58

Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ (2001) 6.17

Patients using the Internet to obtain health information: how this affects the patient-health professional relationship. Patient Educ Couns (2006) 4.21

The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol (2006) 3.76

A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol (2012) 3.72

The impact of health information on the Internet on health care and the physician-patient relationship: national U.S. survey among 1.050 U.S. physicians. J Med Internet Res (2003) 3.48

International comparisons of manpower in gastroenterology. Am J Gastroenterol (2007) 2.95

Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol (2003) 2.86

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med (2003) 2.73

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol (2001) 2.39

Health-information exchange: why are we doing it, and what are we doing? J Am Med Inform Assoc (2011) 2.24

Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis (2011) 2.22

Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol (2000) 2.01

Patient-centered applications: use of information technology to promote disease management and wellness. A white paper by the AMIA knowledge in motion working group. J Am Med Inform Assoc (2007) 1.93

Impact of internet use on health-related behaviors and the patient-physician relationship: a survey-based study and review. J Am Osteopath Assoc (2008) 1.88

Internet use by patients in an inflammatory bowel disease specialty clinic. Inflamm Bowel Dis (2007) 1.85

Quality of web-based information on inflammatory bowel diseases. Inflamm Bowel Dis (2009) 1.81

'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology (Oxford) (2006) 1.67

Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol (2012) 1.61

Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis (2007) 1.42

Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.42

Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci (2007) 1.33

Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol (2007) 1.30

E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22

Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci (2007) 1.16

Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol (2012) 1.15

Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol (2011) 1.12

Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther (2009) 1.01

Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.00

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci (2002) 0.98

Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig (2005) 0.98

Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol (2011) 0.97

Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis (2011) 0.94

Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.94

Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons. Arthritis Care Res (1989) 0.93

Inflammatory bowel disease. Oral Dis (2011) 0.88

Embracing the internet for progress in shared decision-making. Inflamm Bowel Dis (2007) 0.87

Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costs. Adv Ther (2011) 0.85

Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLoS One (2015) 0.83

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol (2012) 0.82

E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance. Dan Med J (2012) 0.79

Compliance, concordance, and patient-centered care. Patient Prefer Adherence (2011) 0.77

Perspectives of family physicians on computer-assisted health-risk assessments. J Med Internet Res (2010) 0.77

Articles by these authors

The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol (2006) 3.76

Superusers in social networks for smoking cessation: analysis of demographic characteristics and posting behavior from the Canadian Cancer Society's smokers' helpline online and StopSmokingCenter.net. J Med Internet Res (2012) 1.45

An online support group for problem drinkers: AlcoholHelpCenter.net. Patient Educ Couns (2007) 1.42

World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol (2012) 1.39

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis (2009) 1.17

Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2007) 1.15

The 1993 Canadian Association of Gastroenterology Strategic Plan: excellence in achievement. Can J Gastroenterol (2003) 1.14

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis (2009) 1.14

Mapping Power Law Distributions in Digital Health Social Networks: Methods, Interpretations, and Practical Implications. J Med Internet Res (2015) 0.90

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease. Inflamm Bowel Dis (2010) 0.89

Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent? J Med Microbiol (2008) 0.86

Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol (2008) 0.85

A randomized trial of topical anesthesia comparing lidocaine versus lidocaine plus xylometazoline for unsedated transnasal upper gastrointestinal endoscopy. Can J Gastroenterol (2010) 0.83

Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis (2015) 0.82

Demographic and Indication-Specific Characteristics Have Limited Association With Social Network Engagement: Evidence From 24,954 Members of Four Health Care Support Groups. J Med Internet Res (2017) 0.79

Behavioral Economics, Wearable Devices, and Cooperative Games: Results From a Population-Based Intervention to Increase Physical Activity. JMIR Serious Games (2016) 0.78

Lessons Learned From Using Focus Groups to Refine Digital Interventions. JMIR Res Protoc (2015) 0.77

Response to letter to the editor. Can J Gastroenterol Hepatol (2014) 0.75

Prevalence and Outcome of Upper Gastrointestinal Bleeding Post-coronary Artery Bypass Graft. Int J Health Sci (Qassim) (2008) 0.75

The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials. J Pharm Pharm Sci (2017) 0.75

A model for partnership and research between the CAG and sponsors. Can J Gastroenterol (2002) 0.75